Fresenius Medical Care AG & Co. KGaA Capital Reinvestment Ratio
Fresenius Medical Care AG & Co. KGaA capital reinvestment ratio. Fresenius Medical Care AG & Co. KGaA (FME) has a Capital Reinvestment Ratio of 0.28x as of June 2026, meaning it reinvests 0% of its operating cash flow (€860.30 Million) in capital expenditures (€240.40 Million). Check total reinvestment intensity of Fresenius Medical Care AG & Co. KGaA to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Fresenius Medical Care AG & Co. KGaA (1998–2025)
Capital reinvestment ratio of Fresenius Medical Care AG & Co. KGaA from 1998 to 2025. This chart tracks Fresenius Medical Care AG & Co. KGaA's Capital Reinvestment Ratio across 28 annual periods. Also explore FME shareholders equity momentum to track the company's year-over-year net asset growth rate.
Fresenius Medical Care AG & Co. KGaA Capital Reinvestment Ratio by Year (1998–2025)
Fresenius Medical Care AG & Co. KGaA capital reinvestment ratio by year from 1998 to 2025. For the full cash flow conversion analysis, see FME cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | €2.68 Billion | €915.37 Million | ▲ +16.5% |
| 2024 | 0.29x | €2.39 Billion | €699.36 Million | ▲ +12.5% |
| 2023 | 0.26x | €2.63 Billion | €684.60 Million | ▼ -60.0% |
| 2022 | 0.65x | €2.17 Billion | €1.41 Billion | ▼ -3.7% |
| 2021 | 0.68x | €2.49 Billion | €1.68 Billion | ▲ +37.1% |
| 2020 | 0.49x | €4.23 Billion | €2.09 Billion | ▼ -43.4% |
| 2019 | 0.87x | €2.57 Billion | €2.24 Billion | ▼ -12.7% |
| 2018 | 1.00x | €2.06 Billion | €2.06 Billion | ▲ +22.7% |
| 2017 | 0.81x | €2.19 Billion | €1.78 Billion | ▼ -14.7% |
| 2016 | 0.95x | €2.03 Billion | €1.94 Billion | ▼ -0.9% |
| 2015 | 0.96x | €1.79 Billion | €1.73 Billion | ▼ -3.2% |
| 2014 | 1.00x | €1.53 Billion | €1.52 Billion | ▲ +170.7% |
| 2013 | 0.37x | €1.47 Billion | €541.64 Million | ▲ +11.0% |
| 2012 | 0.33x | €1.54 Billion | €510.63 Million | ▼ -79.9% |
| 2011 | 1.65x | €1.12 Billion | €1.84 Billion | ▲ +330.6% |
| 2010 | 0.38x | €1.03 Billion | €393.72 Million | ▼ -10.7% |
| 2009 | 0.43x | €934.57 Million | €400.63 Million | ▼ -36.6% |
| 2008 | 0.68x | €730.12 Million | €493.76 Million | ▲ +40.0% |
| 2007 | 0.48x | €822.75 Million | €397.56 Million | ▼ -6.1% |
| 2006 | 0.51x | €687.85 Million | €353.99 Million | ▲ +9.6% |
| 2005 | 0.47x | €565.94 Million | €265.76 Million | ▲ +39.5% |
| 2004 | 0.34x | €610.68 Million | €205.62 Million | ▼ -12.8% |
| 2003 | 0.39x | €598.71 Million | €231.27 Million | ▼ -11.2% |
| 2002 | 0.43x | €524.06 Million | €227.91 Million | ▼ -33.0% |
| 2001 | 0.65x | €476.82 Million | €309.33 Million | ▲ +11.3% |
| 2000 | 0.58x | €416.60 Million | €242.80 Million | ▲ +27.6% |
| 1999 | 0.46x | €348.80 Million | €159.28 Million | ▼ -67.9% |
| 1998 | 1.42x | €228.51 Million | €325.38 Million | — |